###begin article-title 0
Mutations in a Novel, Cryptic Exon of the Luteinizing Hormone/Chorionic Gonadotropin Receptor Gene Cause Male Pseudohermaphroditism
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
###xml 394 399 394 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 510 515 510 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 629 634 629 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 553 561 <span type="species:ncbi:9606">patients</span>
Male pseudohermaphroditism, or Leydig cell hypoplasia (LCH), is an autosomal recessive disorder in individuals with a 46,XY karyotype, characterized by a predominantly female phenotype, a blind-ending vagina, absence of breast development, primary amenorrhea, and the presence of testicular structures. It is caused by mutations in the luteinizing hormone/chorionic gonadotropin receptor gene (LHCGR), which impair either LH/CG binding or signal transduction. However, molecular analysis has revealed that the LHCGR is apparently normal in about 50% of patients with the full clinical phenotype of LCH. We therefore searched the LHCGR for novel genomic elements causative for LCH.
###end p 2
###begin title 3
Methods and Findings
###end title 3
###begin p 4
###xml 102 107 102 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 256 261 256 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 702 707 702 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 333 338 <span type="species:ncbi:9606">human</span>
###xml 470 478 <span type="species:ncbi:9606">patients</span>
###xml 532 540 <span type="species:ncbi:9606">patients</span>
In the present study we have identified a novel, primate-specific bona fide exon (exon 6A) within the LHCGR gene. It displays composite characteristics of an internal/terminal exon and possesses stop codons triggering nonsense-mediated mRNA decay (NMD) in LHCGR. Transcripts including exon 6A are physiologically highly expressed in human testes and granulosa cells, and result in an intracellular, truncated LHCGR protein of 209 amino acids. We sequenced exon 6A in 16 patients with unexplained LCH and detected mutations in three patients. Functional studies revealed a dramatic increase in the expression of the mutated internal exon 6A transcripts, indicating aberrant NMD. These altered ratios of LHCGR transcripts result in the generation of predominantly nonfunctional LHCGR isoforms, thereby preventing proper expression and functioning.
###end p 4
###begin title 5
Conclusions
###end title 5
###begin p 6
###xml 139 144 139 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
The identification and characterization of this novel exon not only identifies a new regulatory element within the genomic organization of LHCGR, but also points toward a complex network of receptor regulation, including events at the transcriptional level. These findings add to the molecular diagnostic tools for LCH and extend our understanding of the endocrine regulation of sexual differentiation.
###end p 6
###begin p 7
Joerg Gromoll and colleagues describe the identification and characterization of a novel exon that appears to be a new regulatory element within the luteinizing hormone/chorionic gonadotropin receptor gene of three individuals with Leydig cell hypoplasia.
###end p 7
###begin title 8
Editors' Summary
###end title 8
###begin title 9
Background.
###end title 9
###begin p 10
###xml 2 8 <span type="species:ncbi:9606">person</span>
###xml 394 400 <span type="species:ncbi:9606">person</span>
###xml 658 664 <span type="species:ncbi:9606">People</span>
A person's sex is determined by their complement of X and Y (sex) chromosomes. Someone who has two X chromosomes is genetically female and usually has ovaries and female external sex organs. Someone who has an X and a Y chromosome is genetically male and has testes and male external sex organs. Sometimes, though, the development of the reproductive organs proceeds abnormally, resulting in a person with an "intersex" condition whose chromosomes, gonads (ovaries or testes), and external sex organs do not correspond. Leydig cell hypoplasia (LCH; also called male pseudohermaphroditism or a disorder of sex development) is an XY female intersex condition. People with this inherited condition develop testes but also have a vagina (which is not connected to a womb), and they do not develop breasts or have periods. This mixture of sexual characteristics arises because the Leydig cells in the testes are underdeveloped. Leydig cells normally secrete testosterone, the hormone that promotes the development and maintenance of male sex characteristics. Before birth, chorionic gonadotropin (CG; a hormone made by the placenta) stimulates Leydig cell development and testosterone production; after birth, luteinizing hormone (LH), which is made by the pituitary gland, stimulates testosterone production. Both hormones bind to the LH/CG receptor, a protein on the surface of Leydig cells. In LCH, this receptor either does not bind CG and LH or fails to tell the Leydig cells to make testosterone.
###end p 10
###begin title 11
Why Was This Study Done?
###end title 11
###begin p 12
###xml 51 56 51 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 183 188 183 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 305 310 305 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 153 159 <span type="species:ncbi:9606">people</span>
###xml 225 231 <span type="species:ncbi:9606">people</span>
The gene that encodes the LH/CG receptor is called LHCGR. Several mutations (genetic changes) that inactivate the LC/CG receptor have been identified in people with LCH. However, the LHCGR gene is apparently normal in 50% of people with this intersex condition. In this study, the researchers examine the LHCGR gene in detail to try to find the underlying genetic defect in these individuals.
###end p 12
###begin title 13
What Did the Researchers Do and Find?
###end title 13
###begin p 14
###xml 106 111 106 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 485 490 485 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 1311 1316 1311 1316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 100 105 <span type="species:ncbi:9606">human</span>
###xml 679 684 <span type="species:ncbi:9606">human</span>
###xml 1260 1266 <span type="species:ncbi:9606">people</span>
The researchers used several molecular biology techniques to identify a new exon-exon 6A-within the human LHCGR gene. (Exons are DNA sequences that contain the information for making proteins; introns are DNA sequences that interrupt the coding sequence of a gene. Both introns and exons are transcribed into messenger RNA [mRNA] and the exons are then "spliced" together to make the mature mRNA, which is translated into protein.) The researchers identify several differently spliced LHCGR mRNA transcripts that contain exon 6A-a terminal exon 6A mRNA that contains exons 1-6 and exon 6A, and two internal exon 6A mRNAs that also contain exons 7-11. The researchers report that human testes express high levels of the terminal exon 6A transcript, which is translated into a short version of LHCGR protein that remains within the cell (full-length LHCGR moves to the cell surface). By contrast, testes contain low levels of the internal exon 6A mRNAs. This is because exon 6A contains two premature stop codons (DNA sequences that mark the end of a protein), which trigger "nonsense-mediated decay" (NMD), a cellular surveillance mechanism that regulates protein synthesis by degrading mRNAs that contain internal stop codons. When the researchers screened 16 people with LCH but without known mutations in the LHCGR gene, three had mutations in exon 6A. Laboratory experiments show that these mutations greatly increased the amounts of the internal exon 6A transcripts present in cells and interfered with the cells' normal response to chorionic gonadotropin.
###end p 14
###begin title 15
What Do These Findings Mean?
###end title 15
###begin p 16
###xml 54 59 54 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 157 162 <span type="species:ncbi:9606">human</span>
These findings identify a new, functional exon in the LHCGR gene and show that mutations in this exon cause some cases of LCH. This is the first time that a human disease has been associated with mutations in an exon that is a target for NMD. In addition, these findings provide important insights into how the LHCGR is regulated. The researchers speculate that a complex network that involves the exon 6A-containing transcripts and NMD normally tightly regulates the production of functional LHCGR already at the transcriptional level. When mutations are present in exon 6A, they suggest, NMD is the predominant pathway for all the exon 6A-containing transcripts, thereby drastically decreasing the amount of functional LHCGR.
###end p 16
###begin title 17
Additional Information.
###end title 17
###begin p 18
Please access these Web sites via the online version of this summary at .
###end p 18
###begin p 19
The MedlinePlus Encyclopedia has a page on  (in English and Spanish)
###end p 19
###begin p 20
Wikipedia has pages on  and on  (note that Wikipedia is a free online encyclopedia that anyone can edit; available in several languages)
###end p 20
###begin p 21
###xml 57 65 <span type="species:ncbi:9606">children</span>
The  provides information and support for the parents of children with intersex conditions
###end p 21
###begin p 22
The Androgen Insensitivity Syndrome Support Group also provides some general information about , including information about  (in several languages)
###end p 22
###begin p 23
, run by a group of researchers in Germany (Leibniz-Institut fur Molekulare Pharmakologie; Humboldt-Universitatzu Berlin), is a database dealing the sequence, structure, and function of glycoprotein hormone receptors
###end p 23
###begin p 24
, from Universite Libre de Bruxelles and Institut de Recherche Interdisciplinaire en Biologie Humaine et Moleculaire, is a database giving structural information on the LHCGR
###end p 24
###begin title 25
Introduction
###end title 25
###begin p 26
###xml 305 310 305 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 539 540 539 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050088-b001">1</xref>
###xml 564 569 564 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 907 908 907 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050088-b002">2</xref>
###xml 1018 1023 1018 1023 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 1054 1055 1054 1055 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050088-b003">3</xref>
###xml 1056 1057 1056 1057 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050088-b004">4</xref>
###xml 1137 1142 1137 1142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 1228 1233 1228 1233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 299 304 <span type="species:ncbi:9606">human</span>
###xml 603 611 <span type="species:ncbi:9606">patients</span>
###xml 947 955 <span type="species:ncbi:9606">patients</span>
The gonadotropic hormones luteinizing hormone (LH) and chorionic gonadotropin (CG) play an essential role in male sexual differentiation. The action of both hormones is mediated by the LH/CG receptor (LHCGR), a G protein-coupled receptor, expressed in Leydig, granulosa-lutein, and theca cells. The human LHCGR gene (NCBI GeneID 3973; ) consists of 11 exons and ten introns, and spans 67 kbp on Chromosome 2 p21. Ten of the 11 exons encode the extracellular domain, while exon 11 encodes the seven-transmembrane and intracellular domains [1]. Several inactivating LHCGR mutations have been described in patients with 46,XY disorder of sex development (46,XY DSD) due to Leydig cell hypoplasia (LCH), an autosomal recessive disorder characterized by a predominantly female phenotype with a blind-ending vagina, absence of breast development, and primary amenorrhea and the presence of testicular structures [2]. However, in a substantial number of patients (50%) with the classical symptoms of LCH, no mutations of the LHCGR are found (unpublished data) [3,4]. This finding raises the hypothesis that genomic defects in other genes or in LHCGR regions not considered so far may cause LCH. In this study we therefore searched the LHCGR gene for novel genomic elements in which genetic alterations could lead to LCH.
###end p 26
###begin title 27
Methods
###end title 27
###begin title 28
###xml 6 18 <span type="species:ncbi:9606">Participants</span>
Study Participants
###end title 28
###begin title 29
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients.
###end title 29
###begin p 30
###xml 313 314 313 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050088-b004">4</xref>
###xml 363 368 363 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 8 16 <span type="species:ncbi:9606">patients</span>
###xml 155 163 <span type="species:ncbi:9606">patients</span>
###xml 321 329 <span type="species:ncbi:9606">patients</span>
Sixteen patients with complete LH resistance (male pseudohermaphroditism) due to LCH type 1 gave written informed consent to participate in the study. All patients had karyotype 46,XY, a blind-ending vagina, no breast development, and testicular structures in the abdomen and displayed the full phenotype of LCH [4]. All patients had been previously screened for LHCGR mutations and found to be negative.
###end p 30
###begin p 31
###xml 4 12 <span type="species:ncbi:9606">patients</span>
The patients in this manuscript have given written informed consent (as outlined in the PLoS publication consent form, ) to publication of their case details.
###end p 31
###begin title 32
Control group.
###end title 32
###begin p 33
###xml 18 21 <span type="species:ncbi:9606">men</span>
###xml 224 235 <span type="species:ncbi:9606">participant</span>
Forty-one fertile men with normal LH and testosterone levels and normal spermatogenesis were included as a control group. The institutional review board approved the study and written informed consent was obtained from each participant.
###end p 33
###begin title 34
Case reports.
###end title 34
###begin p 35
###xml 22 27 <span type="species:ncbi:9606">woman</span>
###xml 141 149 <span type="species:ncbi:9606">children</span>
A 20-year-old Turkish woman was referred to the gynecologist because of primary amenorrhea. She was the first daughter of a sibship of three children from consanguineous parents. She presented with a lack of breast development, normal pubic and axillary hair, blind-ending vagina (4 cm), and normal labia majora and minora. No clitoris hypertrophy was seen. She was obese (122 kg, 173 cm). Testes were palpable in the inguinal regions, but no mullerian derivatives were found by ultrasound. Karyotyping was performed and revealed a 46,XY karyotype. Hormone analysis showed very low serum testosterone levels (0.1 nmol/l), which could be not stimulated by treatment with 7,500 IU of hCG (maximal testosterone levels, 0.1 nmol/l). Serum levels of LH and FSH were elevated (LH 15.8 IU/l, FSH 13.6 IU/l) and responsive to stimulation with 100 mug of GnRH (LH 69.8 IU/l, FSH 20.1 IU/l).
###end p 35
###begin p 36
###xml 883 888 882 887 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
At the age of 26 y her sister, younger by 6 y, was referred to the Department of Endocrinology of the University of Essen also because of primary amenorrhea. She presented with the same phenotype as her older sister: 46,XY karyotype, blind-ending vagina (6 cm), inguinal gonads, obesity (126 kg, 176 cm), low estradiol level (21 pg/ml), low testosterone level (0.06 nmol/l, increasing to 1.9 nmol/l after 7,500 IU of hCG), elevated gonadotropin level (LH 24.3 IU/l, FSH 20.1 IU/l) responsive to 100 mug of GnRH (LH 98.0 IU/l, FSH 29.6 IU/l). Gonadectomy was performed and histological evaluation revealed complete Sertoli cell-only syndrome with thickened tubule walls and focally disorganized tubules. Leydig cells appeared immature and their number was not evidently changed when compared to normal testes. In both affected sisters the previously performed genetic analysis of the LHCGR gene did not give any hint of mutations or other genetic alterations in other candidate genes.
###end p 36
###begin p 37
###xml 50 55 50 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 456 461 456 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 8 15 <span type="species:ncbi:9606">patient</span>
###xml 293 297 <span type="species:ncbi:9606">girl</span>
A third patient was analyzed for mutations in the LHCGR gene at the age of 21 mo. She was born to unrelated parents and presented a female phenotype with labial synechia. Gonads were palpable in both labia majora and a karyotype 46,XY was found. Postnatal testosterone levels were low and the girl was gonadectomized at the age of 2 mo. Histology showed fibrotic testis tissue. A heterozygous mutation leading to a Thr461Ile substitution in exon 11 of the LHCGR gene, resulting in complete inactivation, was found.
###end p 37
###begin title 38
Cells and Tissues
###end title 38
###begin p 39
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 40 48 <span type="species:ncbi:9606">patients</span>
###xml 140 145 <span type="species:ncbi:9606">women</span>
###xml 227 235 <span type="species:ncbi:9606">patients</span>
###xml 296 301 <span type="species:ncbi:9606">human</span>
Human testis tissues were obtained from patients undergoing orchidectomy because of prostate cancer, and granulosa cells were obtained from women undergoing assisted reproduction. Written informed consent was obtained from the patients to use their material for scientific research. In addition, human adrenal and testis RNA was purchased from a commercial source (Biocat, Heidelberg, Germany).
###end p 39
###begin p 40
###xml 221 240 221 240 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Macaca fascicularis</named-content>
###xml 512 513 512 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050088-b005">5</xref>
###xml 202 219 <span type="species:ncbi:9541">cynomolgus monkey</span>
###xml 221 240 <span type="species:ncbi:9541">Macaca fascicularis</span>
###xml 447 464 <span type="species:ncbi:9541">cynomolgus monkey</span>
Snap-frozen testes were obtained from different primate species within the framework of a project on efficacy of spermatogenesis funded by the German Research Foundation (WE1167/4-1/2). Tissue from the cynomolgus monkey (Macaca fascicularis) was obtained from our own primate colonies at the Institute of Reproductive Medicine (Muenster, Germany). All experiments were conducted according to the German Law on Animal Care and Experimentation. The cynomolgus monkey testis cDNA library has been described before [5].
###end p 40
###begin title 41
Genomic DNA and RNA Isolation
###end title 41
###begin p 42
Genomic DNA was isolated from EDTA-treated blood samples using the Flexigene DNA isolation kit (Hilden, Germany). RNA was isolated using UltraSpec (Biotecx, Houston, Texas, United States).
###end p 42
###begin title 43
Exon Trap Experiments
###end title 43
###begin p 44
###xml 283 288 283 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 173 178 <span type="species:ncbi:9606">human</span>
Analysis of exon 6A was performed using the exon trapping system (Invitrogen, Karlsruhe, Germany). Plasmid constructs were generated by amplification of a DNA fragment from human genomic DNA using the specific primers Ex6a 150 fw (forward) 5'-CGCTCGAGCCTGCCCTCCTCGGCCTCCCAAAG-3' and LHCGR Ex6a 150 rev (reverse) 5'-CGCGGATCCCTTTATAAGCAGCCGGTAGAGCTG-3' containing the restriction site Xho1 within the forward primer or BamH1 for the reverse primer. The fragment was amplified using the following thermocycler conditions: 94 degreesC for 50 s, 64 degreesC for 50 s, 72 degreesC for 90 s for 35 cycles. The obtained amplicon was restricted by Xho1 and BamH1 and cloned into the pSPL3 vector. Sequence fidelity was confirmed by DNA sequencing.
###end p 44
###begin title 45
Transient Transfection and Reverse Transcription PCR
###end title 45
###begin p 46
COS7 cells were seeded on petri dishes and cultured to 40%-50% confluency. 12 mug of plasmid DNA per dish was used for transfection by Lipofectamine (Invitrogen, 12 mul/dish). 6 h later the transfection was stopped by adding DMEM supplemented with 20% FCS. 48 h later the cells were lysed using UltraSpec and RNA isolated according to the manufacturer's protocol. Reverse transcription was performed using the vector-specific primers SA2 5'-TCTGAGTCACCTGGACAACC-3' and exon 6A rev (reverse) 5'-GTAACATGACAATTATACATG-3', or beta-actin reverse primer as a control for RNA integrity. Subsequent PCR was performed with the primer combination SD6 5'-ATCTCAGTGGTATTTGTGAGC-3' and SA2 (see above), or SD6/exon 6A rev (reverse) and beta-actin for/rev (forward/reverse) using the following thermocycler conditions: 94 degreesC for 50 s, 60 degreesC for 50 s, 72 degreesC for 90 s for 35 cycles. The PCR reactions were subjected to 2% agarose gel electrophoresis and documented using the Multi-Image Light system (Biozym, Oldendorf, Germany). In functional experiments, COS7 cells were stimulated 24 h after transfection by hCG (Choragon, Ferring GmbH, Kiel Germany) dissolved in DMEM. Extracellular cAMP concentrations were determined 3 h after stimulation in media by radioimmunoassay.
###end p 46
###begin title 47
In Vitro Mutagenesis
###end title 47
###begin p 48
Mutations were introduced using the Quick Change site-directed mutagenesis kit from Stratagene (Heidelberg, Germany). Sequence fidelity was confirmed by DNA sequencing.
###end p 48
###begin title 49
###xml 63 68 63 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
Real-Time Quantitative PCR for the Relative Gene Expression of LHCGR Variants
###end title 49
###begin p 50
###xml 56 61 56 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 132 137 132 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 208 213 208 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 486 491 486 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
The commercially available TaqMan assay #HS20896337_m1 (LHCGR; Applied Biosystems, Darmstadt, Germany) was used to detect the known LHCGR transcripts (without exon 6A). For the relative quantification of the LHCGR terminal exon 6A and internal exon 6A variants, specifically designed assays were used. The terminal exon 6A assay is directed toward the 3' region of exon 6A, while the internal exon 6A variants are detected by an assay spanning the 5' region of exon 6A to exon 7 of the LHCGR gene. The primers and probes of the assays designed ad hoc are listed below.
###end p 50
###begin title 51
Terminal exon 6A.
###end title 51
###begin p 52
Forward primer, 5'-CAGAGGACTCTCTTTTATATCACTGGATTC-3'; reverse primer, 5'-TGGTCACAGCTTTGTAACATGACAA-3'; TaqMan MGB FAM-labeled probe, 5'-ACCAAGGATACCAATTTT-3'
###end p 52
###begin title 53
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
LHCGR internal exon 6A short.
###end title 53
###begin p 54
Forward primer, 5'-CTCTGAAATGAAGAGATAGATGTGAAGCA-3'; reverse primer, 5'-GCATGACTTTGTACTTCTTCAAATCCAT-3'; TaqMan MGB FAM-labeled probe, 5'-TTCCATATAGTTTGCAATTTT-3'.
###end p 54
###begin title 55
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
LHCGR internal exon 6A long.
###end title 55
###begin p 56
Forward primer, 5'-CAGAGGACTCTCTTTTATATCACTGGATTC-3'; reverse primer, 5'-TGACTTTGTACTTCTTCAAATCCATTTCCA-3'; TaqMan MGB Fam-labeled probe, 5'-ACTGCCTTTGTATAGTACTTTTA-3'.
###end p 56
###begin title 57
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
LHCGR exon 6/7 without exon 6A.
###end title 57
###begin p 58
Forward primer, 5'-ACCACCATACCAGGAAATGCTTTT-3'; reverse primer, 5'-AAAGATTCAGTGTCGTCCCATTGA-3' (AAAGAT correspond to vector sequence); TaqMan MGB Fam-labeled probe, 5'-CAAGGGATGAATAATGAATCTGT-3'
###end p 58
###begin title 59
Assays.
###end title 59
###begin p 60
Reverse transcription of 2 mug of total RNA/tissue was performed using random hexamer primers and Superscript II enzyme according to the manufacturer's protocol (Invitrogen).
###end p 60
###begin p 61
###xml 339 344 315 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
TaqMan PCR was performed using the following amplification profile: an initial step consisting of 50 degreesC for 2 min and 95 degreesC for 10 min followed by 40 cycles at 95 degreesC for 15 s and 60 degreesC for 1 min. PCR efficiency was verified with different cDNA concentrations yielding linear amplification. For the detection of the LHCGR variants 200 ng of cDNA per reaction were used.
###end p 61
###begin p 62
###xml 87 88 87 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050088-b006">6</xref>
###xml 101 114 101 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;&#916;&#916;CT</sup>
###xml 271 276 263 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
The relative quantification of gene expression was analyzed according to Livak et al. [6] using the 2-DeltaDeltaCT method. Normalization of RNA content was performed using 18S TaqMan gene expression assay (Hs # 99999901; Applied Biosystems). The mRNA levels of the known LHCGR (without exon 6A) in the testis tissue were used to calibrate by relative quantification the expression levels of the other transcripts.
###end p 62
###begin title 63
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
LHCGR Minigene Constructs
###end title 63
###begin p 64
###xml 132 139 <span type="species:ncbi:9606">patient</span>
The genomic region encompassing exon 6, exon 6A, and exon 7, with a total length of 9,534 bp, was amplified from genomic DNA of one patient with the A557C mutation and one male individual lacking the mutation using the Expand Long PCR kit by Roche (Mannheim, Germany). The following two primers and manufacturer-recommended thermocycler conditions were used: exon 6 for (forward) 5'-GTGATAACTTACACATAACCACCATACCAGG-3' and exon 7 rev (reverse) 5'-GTCAGTGTCGTCCCATTGAATGCATGAC-3'). The obtained amplicons were cloned into the pTarget expression plasmid (Promega, Germany) and sequence fidelity was confirmed by DNA sequencing.
###end p 64
###begin p 65
###xml 164 169 164 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 380 385 380 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 1455 1460 1455 1460 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
These constructs were further modified for signal transduction studies. To mimic the in vivo situation as close as possible we engineered a construct consisting of LHCGR cDNA and embedding the genomic intron 6 with exon 6A. To reduce the length of the intron to a manageable size the minigene constructs with the genomic region encompassing intron 6 from both wild-type and A557C LHCGR were digested with EcoRV, 6,209 bp were removed from the intronic region 3' of exon 6A, and the remaining parts were re-ligated. A functional analysis of the shortened constructs revealed a similar splicing pattern to the full-length construct. Thereafter, a three-step cloning strategy was employed. In the first step cDNA from exons 1-6 was amplified and joined to the 5' end of the shortened minigene construct by overlapping PCR, yielding a product containing exons 1-6, shortened intron 6, and exon 7; this product was subsequently cloned into the pTarget vector. In the second step, the 3' end of shortened minigene construct was joined to exons 7-11, yielding a product containing exon 6, shortened intron 6, and exons 6-11; this product was also cloned into the pTarget vector. In the third step both constructs were digested with SacI and a fragment containing exons 1-6 and extending into the intronic region was used to replace the 5' part of the construct encoding exon 6, intron 6, and exons 7-11. The resulting construct consisted of a chimera of partial LHCGR cDNAs and intron 6 containing exon 6A. Sequence fidelity was repeatedly verified by complete DNA sequencing of the different constructs. Primers used for amplification were as follows. LHCGR exons 1-6, forward primer 5'-ATGAAGCAGCGGTTCTCGGCGCTGC-3'; reverse primer 5'-GCATTTCCTGGTATGGTGGTTATGTGTAAGTTATCAC-3'. LHCGR exons 7-11, forward primer 5'-CAAACTATATGGAAATGGATTTGAAGAAG-3'; reverse primer 5'-TTAACACTCTGTGTAGCGAGTCTTGTC-3'.
###end p 65
###begin title 66
Northern Blot Hybridization.
###end title 66
###begin p 67
###xml 373 378 367 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 468 470 458 460 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 505 506 495 496 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 62 67 <span type="species:ncbi:9606">Human</span>
###xml 367 372 <span type="species:ncbi:9606">human</span>
Northern blots were either obtained from a commercial source (Human Adult Normal Tissue, Blot V, Biocat, Heidelberg, Germany,) or made from adult marmoset tissues (ovary, liver, muscle). Membranes were hybridized using the FastHyb Solution (BioChain, Heidelberg, Germany) at 42 degreesC overnight. As probes either a fragment containing only exon 6A or a full-length human LHCGR cDNA (lacking exon 6A) were used. Both probes were radioactively labeled using alpha-dCTP32 with specific activity of > 2 x 107 cpm/mug DNA. Blots were sequentially hybridized to the two probes. After hybridization washing was performed using 0.1 SSC/0.5% SDS at 65 degreesC. Blots were exposed for 1-6 h in Phosphorimager cassettes and developed by a Phosphorimager (Storm 860, Molecular Dynamics)
###end p 67
###begin title 68
###xml 38 43 38 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 55 60 55 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
Protein Expression of the Full-Length LHCGR and of the LHCGR Terminal Exon 6A Variant
###end title 68
###begin p 69
###xml 100 105 100 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 264 269 264 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 412 417 412 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 550 555 550 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 630 635 630 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 71 76 <span type="species:ncbi:9606">human</span>
The protein expression studies of LHCGR exon 6A were performed using a human HA-tagged, full length LHCGR cDNA cloned into the pcDPS expression plasmid (kindly provided by Dr. T. Gudermann, University of Marburg, Germany). The HA tag is directly located after the LHCGR signal peptide and can be visualized by immunofluorescence using a HA-specific antibody (sc 7392, Santa Cruz, California, United States). The LHCGR exon 6A variant was generated by a restriction enzyme-based cloning strategy, using Hind III and Spe1, thereby removing most of the LHCGR cDNA except the most N-terminal part, which subsequently was joined to an LHCGR exon 6A variant treated with the same restriction enzymes beforehand. Both constructs were transiently transfected into COS7 cells and immunofluorescence was detected by using the HA antibody followed by a monoclonal IgG2a antibody (Sigma, Deisenhofen, Germany) and fluorescence was imaged by a Zeiss Axioscope microscope.
###end p 69
###begin title 70
Web Resources
###end title 70
###begin p 71
###xml 277 282 277 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 266 276 <span type="species:ncbi:9598">Chimpanzee</span>
Sequence alignments were performed using the ClustalW program (). Exon splicing binding sites were identified using the exon splicing enhancer (ESE) finder software (). Other searches were performed using the toolbox of the Alternative Splicing Database project (). Chimpanzee LHCGR sequences were extracted from the NCBI Nucleotide database at .
###end p 71
###begin title 72
Results
###end title 72
###begin title 73
###xml 34 39 34 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
A Cryptic, Functional Exon in the LHCGR Gene
###end title 73
###begin p 74
###xml 23 28 23 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 117 122 117 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 174 179 174 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 316 324 316 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050088-g001">Figure 1</xref>
###xml 424 429 424 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 619 620 619 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050088-b007">7</xref>
###xml 785 793 785 793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050088-g001">Figure 1</xref>
###xml 818 823 818 823 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 942 947 942 947 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 87 92 <span type="species:ncbi:9606">human</span>
###xml 418 423 <span type="species:ncbi:9606">human</span>
###xml 812 817 <span type="species:ncbi:9606">human</span>
In our effort to clone LHCGR variants we screened a cynomolgus testis cDNA library and human granulosa cell mRNA for LHCGR transcripts, and systematically identified unusual LHCGR variants consisting of exons 1 to 6 and additional unknown sequences either terminated by a poly(A) tail or continuing with exons 7-11 (Figure 1A). A BLAST search yielded a perfect match to the intronic region between exon 6 and 7 of the human LHCGR gene (from nucleotide position 33,900 to 34,200). Inspection revealed the presence of a 3' splice acceptor site (AG) and a 3' polyadenylation signal (AATAAA) indicative of a terminal exon [7]. Moreover, two internal 5' splice sites were evident which, together with the 3' acceptor site, give rise to a 159 bp (short) or to a 207 bp (long) internal exon (Figure 1B). Therefore, the human LHCGR gene contains an additional, previously unrecognized putative exon within intron 6 that can be spliced into the novel LHCGR transcripts following two different routes. We designated this new exon as exon 6A.
###end p 74
###begin title 75
Identification and Characterization of Exon 6A
###end title 75
###begin p 76
###xml 111 116 111 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 248 253 248 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 334 339 334 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
(A) Upper diagram: Schematic representation of the composite internal/terminal exon 6A and its location in the LHCGR gene. The asterisk indicates the translational stop codon. 5' SS indicates the 5' splicing sites. Middle diagram: Structure of the LHCGR mRNA when exon 6A is acting as a terminal exon. Lower diagram: Structure of the LHCGR mRNA when exon 6A is acting as an internal exon.
###end p 76
###begin p 77
###xml 445 450 445 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
(B) cDNA nucleotide sequence and putative amino acid sequence of exon 6A. The three different variants of exon 6A are indicated by the grey line (internal short and long exon 6A) and black line (terminal exon 6A). Stop codons are underlined and the polyadenylation signal is boxed. The 3' and 5' splice sites are indicated by small arrows and the position of the identified mutations by bold arrows. Numbering of nucleotides is according to the LHCGR mRNA where the translational initiation codon ATG is considered as +1 (adenosine).
###end p 77
###begin p 78
###xml 200 208 200 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050088-g002">Figure 2</xref>
###xml 323 331 323 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050088-g002">Figure 2</xref>
###xml 434 439 434 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 661 666 661 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 790 798 790 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050088-g003">Figure 3</xref>
###xml 1192 1197 1192 1197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 1215 1223 1215 1223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050088-g003">Figure 3</xref>
###xml 31 36 <span type="species:ncbi:9606">human</span>
###xml 763 768 <span type="species:ncbi:9606">human</span>
Exon trap experiments with the human genomic region surrounding exon 6A yielded two transcripts including either 159 bp (short) or 207 bp (long) of the internal exon 6A, indicating specific splicing (Figure 2A, agarose gel lane 1). A different primer set revealed the expression of the terminal exon 6A transcript as well (Figure 2B, agarose gel lane 1). Thus, exon 6A is a novel bona fide composite internal/terminal exon within the LHCGR gene. However, these experiments did not give any clues as to the presence of these exon 6A variants in native tissues. Therefore, using a different approach we analyzed and quantified the expression pattern of the known LHCGR mRNA and of the newly discovered transcripts by real-time reverse transcription PCR (RT-PCR) in human tissues. As shown in Figure 3, high mRNA levels including exon 6A were detected in granulosa cells and in testes, where the terminal variant expression is about five times higher than that of the known mature mRNA without exon 6A. In addition, low levels of exon 6A transcripts were consistently detected in adrenal tissues. mRNA levels for the two internal exon 6A mRNA variants were significantly lower than in the known LHCGR without exon 6A (Figure 3).
###end p 78
###begin title 79
Exon 6A Is a Bona Fide Exon
###end title 79
###begin p 80
###xml 80 85 80 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 74 79 <span type="species:ncbi:9606">human</span>
Exon trap experiments with exon 6A. A genomic fragment of intron 6 of the human LHCGR gene including exon 6A and 150 bp upstream and downstream was cloned into the pSPL3 expression vector. COS7 cells were transiently transfected with this construct and RT-PCR performed. Primers for the detection of either internal exon 6A (A) or terminal exon 6A (B) are indicated by the arrows. A representative gel electrophoresis is shown below each expected PCR product. RT-PCR results of COS7 cells transfected with either the pSPL3 construct containing exon 6A (lane 1) or empty pSPL3 vector (lane 2) or untransfected COS7 cells (lane 3 in [A]) are shown. The agarose gel photograph in (B) displays the detection of the spliced terminal exon 6A variant. This splice variant can be obtained only in the exon trap system, when using a primer combination employing SD6 and 6A rev (lane 1 in [B]). In addition to the spliced mRNA variant a second amplicon arose by amplification of a partial fragment of the pSPL3 vector and the DNA construct covering 150 bp 5' to exon 6A and exon 6A. The second amplicon, deriving from the DNA construct is therefore also detectable in a reaction omitting the RT-synthesis (lane 3 in [B]). RNA fidelity was confirmed by the detection of beta-actin mRNA. These results show that exon 6A is recognized as a bona fide exon and is spliced to give rise to two internal (A) and one terminal variant (B) mRNAs, as predicted by the primary genomic sequence.
###end p 80
###begin title 81
Tissue-Specific Expression of Exon 6A mRNA
###end title 81
###begin p 82
###xml 18 23 18 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 49 54 <span type="species:ncbi:9606">human</span>
###xml 101 106 <span type="species:ncbi:9606">human</span>
Quantification of LHCGR transcripts in different human tissues by TaqMan RT-PCR. mRNA extracted from human testes and granulosa cells and from a commercially available adrenal gland preparation was analyzed. After normalization against 18S RNA, results were quantified with the testis transcript without exon 6A as the reference that was assigned an arbitrary unit (AU) value of 1. Results are shown as mean +/- SEM of three independent experiments. The amplicon without exon 6A represents the transcript that results in the mature, full-length LHCGR protein. Transcripts containing the terminal exon 6A are highly expressed in all tissues analyzed and show a 6-fold higher expression compared to those without exon 6A in testis and adrenal gland. In comparison, the expression level of the internal exon 6A transcripts is much lower in every tissue.
###end p 82
###begin p 83
###xml 287 296 287 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0050088-sg001">Figure S1</xref>
###xml 299 300 299 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050088-b008">8</xref>
###xml 301 302 301 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050088-b009">9</xref>
###xml 585 594 585 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0050088-sg001">Figure S1</xref>
###xml 67 77 <span type="species:ncbi:9598">chimpanzee</span>
###xml 550 555 <span type="species:ncbi:10090">mouse</span>
The genomic region including exon 6A is perfectly conserved in the chimpanzee as shown by database sequence comparison. Moreover, we cloned and sequenced the corresponding genomic region in macaque, marmoset monkey, and lemur as representative species of the principal primate lineages (Figure S1) [8,9]. Exon 6A presumably arose from a 2.7 kbp insertion, which was found in all primates investigated in this study. Both the internal and the terminal exon 6A are highly conserved in these primates, but comparable sequences are completely lacking in mouse as well as in other species (Figure S1).
###end p 83
###begin p 84
###xml 50 55 50 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 113 121 113 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050088-g001">Figure 1</xref>
###xml 449 454 449 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 557 566 557 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0050088-sg003">Figure S3</xref>
###xml 611 616 611 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 823 825 823 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050088-b010">10</xref>
###xml 996 1004 996 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050088-g004">Figure 4</xref>
###xml 1232 1237 1232 1237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 1377 1382 1377 1382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
Exon 6A maintains phase 2 splicing typical of the LHCGR exon organization. However, it contains two stop codons (Figure 1) and encodes 30 amino acids (pI = 4.5) with no significant sequence homology to any other known protein according to FASTA and BLAST searches. The incorporation of either terminal or internal exon 6A into the transcripts results in a truncated LHCGR protein of 209 amino acids. The expression of such protein using a HA-tagged LHCGR-exon 6A vector in transiently transfected COS7 cells revealed a predominantly cytosolic localization (Figure S3). The presence of stop codons qualifies the LHCGR transcript containing the internal exon 6A as a target for NMD, a recently described protein-mediated surveillance mechanism that selectively degrades nonsense mRNAs, thereby regulating protein expression [10]. Elimination of the stop codons by in vitro mutagenesis significantly increased the efficiency of internal exon 6A inclusion rate in transiently transfected COS7 cells (Figure 4). Similar results were obtained when transfected cells were treated with cycloheximide, a strong protein synthesis inhibitor, for 4 h (unpublished data). These results indicate that exon 6A might function as novel regulator of LHCGR mRNA levels and transcript pattern. Upon inclusion of the internal exon 6A, an NMD-mediated process probably results in degradation of the LHCGR transcript, while inclusion of terminal exon 6A result in an intracellular, truncated LHCGR protein. Whether the deduced truncated 209 amino acid protein occurs naturally in testis and ovary remains unknown because appropriate antibodies are not available.
###end p 84
###begin title 85
Mutation and Stop Codons Effect Exon 6A mRNA Expression
###end title 85
###begin p 86
###xml 435 443 435 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050088-g002">Figure 2</xref>
###xml 807 808 805 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Analysis of internal exon 6A inclusion in exon trap experiments showing that removal of the two stop codons (stop) or the presence of the A557C mutation significantly increases inclusion of the internal exon 6A variants. Upper image The expression of the terminal and internal variants was analyzed after transfection in COS7 cells and RT-PCR of pSPL3 constructs containing the wild-type (WT) exon 6A (along with 150 bp 5' and 3': see Figure 2) or exon 6A after removal of the two stop codons (stop) or the introduction of the A557C mutation. Lower histogram: Densitometric quantification (in arbitrary units, AU) of internal exon 6A variants RT-PCR results (both short and long variant together) of three or four independent experiments, as indicated in the columns. Results are expressed as mean +/- SEM. p = 0.0294 (Kruskall-Wallis test). Results suggest that removal of the stop codons or a mutation in the SRp55 site reduces NMD of the internal exon 6A transcripts.
###end p 86
###begin p 87
###xml 208 213 208 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 236 244 236 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050088-g005">Figure 5</xref>
###xml 658 663 658 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 720 725 720 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 805 810 805 810 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 264 269 <span type="species:ncbi:9606">human</span>
###xml 382 387 <span type="species:ncbi:302767">comet</span>
###xml 467 472 <span type="species:ncbi:9606">human</span>
###xml 546 551 <span type="species:ncbi:302767">comet</span>
In order to further verify the natural occurrence of mRNA transcripts including exon 6A, we performed Northern blot hybridization experiments using specific probes containing either only exon 6A or the whole LHCGR cDNA without exon 6A (Figure 5). Hybridization of human and marmoset ovarian mRNA revealed a unique and consistent binding pattern of the exon 6A probe resulting in a "comet-like" pattern in the range of 0.5 to 1.4 kb. This finding was specific for the human and marmoset ovary and was not observed in any other tissues tested. The comet-like appearance of exon 6A hybridization in the presence of distinct band patterns characteristic for the LHCGR mRNA (ranging from 2.3 to 9.5 kb) using the full-length LHCGR cDNA probe, suggests mRNA degradation, consistent with the hypothesis that the LHCGR exon 6A internal variants probably undergo NMD.
###end p 87
###begin title 88
Exon 6A-Specific Transcripts as Detected by Northern Blot Hybridization
###end title 88
###begin p 89
###xml 197 202 197 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 49 54 <span type="species:ncbi:9606">human</span>
###xml 179 184 <span type="species:ncbi:9606">human</span>
Commercially available Northern blots containing human adult normal tissues and Northern blots from adult marmoset tissues were sequentially hybridized to an exon 6A probe or the human full-length LHCGR cDNA.
###end p 89
###begin p 90
###xml 57 62 57 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 136 141 136 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 462 467 462 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 482 487 <span type="species:ncbi:302767">comet</span>
Lanes 1 and 4, exon 6A probe. Lanes 2 and 5, full-length LHCGR cDNA probe. Lanes 3 and 6, negative control tissues hybridized either to LHCGR cDNA (lane 3) or to exon 6A (lane 6). Blots were exposed for 1-6 h using a Phosphorimager. An RNA marker was used for size determination of the different transcripts. One Northern blot hybridization out of three independent experiments is shown. While a range of discrete transcripts is identified using the full-length LHCGR cDNA probe, a comet-like hybridization pattern, probably representing degraded mRNA transcripts, is detected by an exon 6A-specific probe. These results indicate that (i) transcripts containing exon 6A are naturally present in the ovary and (ii) they undergo massive degradation, possibly by NMD. beta-actin hybridization results are given to demonstrate RNA integrity.
###end p 90
###begin title 91
Mutations of Exon 6A Are Associated with LCH/46,XY DSD
###end title 91
###begin p 92
###xml 112 117 112 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 361 366 361 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 786 794 786 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0050088-st001">Table S1</xref>
###xml 45 53 <span type="species:ncbi:9606">patients</span>
###xml 636 643 <span type="species:ncbi:9606">patient</span>
We screened 16 clinically well-characterized patients with the overt phenotype of LCH and no known mutations in LHCGR gene for genetic alterations in exon 6A. Three single nucleotide polymorphisms (SNPs) were identified, for which the first represents a nonsynonymous SNP at nucleotide position 599 (starting from exon 1, rs4637137, NCBI-SNP database, ) of the LHCGR changing ATG (Met) into ACG (Thr). The other two SNPs are located at nucleotide position A653G (rs4490239, SNP database) and at nucleotide position T748G (not found in the SNP database) within the noncoding region of exon 6A. Determination of the different SNPs in the patient group and in a cohort of 41 males lacking mutations showed similar distribution and frequencies. The SNPs T599C and A653G appear to be in LD (Table S1).
###end p 92
###begin p 93
###xml 287 288 287 288 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</underline>
###xml 300 301 300 301 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</underline>
###xml 305 313 305 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050088-g001">Figure 1</xref>
###xml 563 568 563 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 724 733 724 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0050088-sg003">Figure S3</xref>
###xml 951 957 951 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR,</italic>
###xml 1040 1049 1040 1049 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0050088-sg005">Figure S5</xref>
###xml 1130 1139 1130 1139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0050088-sg005">Figure S5</xref>
###xml 96 104 <span type="species:ncbi:9606">patients</span>
###xml 325 333 <span type="species:ncbi:9606">patients</span>
###xml 819 826 <span type="species:ncbi:9606">patient</span>
Apart from these SNPs present also in an appropriately sized control group, we identified three patients from two families with mutations of exon 6A. In two sisters with LCH we found a homozygous A to C mutation at position 557 within exon 6A, leading to an amino acid change from Glu (GAG) to Ala (GCG) (Figure 1B). The two patients were from consanguineous parents who each carried the same heterozygous mutation, but without any apparent phenotype. An immunofluorescence-based comparison of the mutated LHCGR terminal exon 6A protein variant using a HA-tagged LHCGR and the wild-type LHCGR terminal exon 6A protein variant yielded no obvious difference; in both cases a predominantly cytosolic localization was observed (Figure S3). A heterozygous G to C transversion at position 558 of exon 6A was found in another patient with LCH from an independent family who was concomitantly carrier of a heterozygous inactivating mutation in exon 11 of the LHCGR, leading to the complete absence of signal transduction upon stimulation with hCG (Figure S5A). The two mutations were located on different alleles (compound heterozygosis; Figure S5B).
###end p 93
###begin p 94
###xml 169 171 169 171 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CG</underline>
###xml 261 266 261 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 382 390 382 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050088-g004">Figure 4</xref>
###xml 428 437 428 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0050088-sg005">Figure S5</xref>
###xml 492 497 492 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 795 803 795 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050088-g006">Figure 6</xref>
###xml 1143 1151 1143 1151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050088-g006">Figure 6</xref>
###xml 544 551 <span type="species:ncbi:9606">patient</span>
According to the ESE finder software, the A557C mutation strengthens and the G558C mutation abolishes a binding site for the splicing factor SRp55 (consensus sequence TGCGTC, mutation sites underlined). We therefore analyzed the effects of the mutations on the LHCGR transcript pattern in vitro. Exon trap experiments revealed a 4-fold higher expression level of the A557C exon 6A (Figure 4) and a 6-fold increase of the G558C (Figure S5C) internal variants compared to wild type. The entire LHCGR genomic region from exon 6 to exon 7 from one patient with the A557C exchange and from one control were cloned and expressed in COS7 cells, and the transcript pattern quantified by real-time RT-PCR. The mutation did not induce any change in the expression level of the transcript without exon 6A (Figure 6). However, the transcript containing the mutated, terminal exon 6A showed 2.5-fold higher levels compared to the wild type. The long internal exon 6A variant was about 5-fold more expressed, whereas for the short internal exon 6A variant the expression level changed dramatically, with about 3,000-fold increase compared to the wild type (Figure 6).
###end p 94
###begin title 95
The A557C Mutation Increases the Expression of the Exon 6A Short Internal Variant
###end title 95
###begin p 96
###xml 67 72 67 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 87 94 <span type="species:ncbi:9606">patient</span>
A 9.5 kb genomic DNA fragment encompassing exon 6 to exon 7 of the LHCGR gene from one patient carrying the A557C mutation and one control (wild type) was cloned into the pTarget expression vector and transiently transfected in COS7 cells. Expression of each variant was quantified by TaqMan RT-PCR. Results of three independent experiments (mean +/- SEM) are expressed in arbitrary units (AU) after relative quantification against the respective wild-type variant, which was arbitrarily given an AU value of 1.
###end p 96
###begin p 97
###xml 260 268 260 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050088-g007">Figure 7</xref>
###xml 428 434 428 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR,</italic>
###xml 502 510 502 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050088-g007">Figure 7</xref>
###xml 967 975 967 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050088-g007">Figure 7</xref>
###xml 1075 1080 1075 1080 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
In order to assess the functional consequences of the mutation we conducted signal transduction studies using constructs consisting of two cDNAs covering exons 1-6 and 7-11 joined by a fragment of intron 6 including exon 6A with or without the A557C mutation (Figure 7A). Functionality at the transcriptional level was tested in transiently transfected COS7 cells. Using primer combinations directed to exon 6 and exon 7 of the LHCGR, RT-PCR yielded a predominantly expressed amplicon lacking exon 6A (Figure 7B). However, this pattern was completely reversed when analyzing the A557C mutation, which resulted in inclusion of both short and long variants of exon 6A. In functional experiments, increasing doses of hCG were able to significantly increase extracellular cAMP concentrations only when the cells were transfected with the expression vector containing the wild-type minigene, while response was practically abolished in the presence of the A557C mutation (Figure 7C). These data suggest that the mutation in exon 6A specifically alters the splicing pattern of the LHCGR gene, with a large increase of transcripts not contributing to the generation of the mature, full-length receptor protein, and it thereby prevents the physiological cAMP response to hCG stimulation.
###end p 97
###begin title 98
The A557C Mutation Abolishes LHCGR Response to hCG
###end title 98
###begin p 99
###xml 54 59 54 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 143 148 143 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 234 239 234 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 161 168 <span type="species:ncbi:9606">patient</span>
(A) Minigenes were generated by ligating together the LHCGR cDNA from exons 1-6, the genomic DNA fragment encompassing exon 6 to exon 7 of the LHCGR gene from a patient carrying the A557C mutation and one control (wild type), and the LHCGR cDNA from exons 7-11.
###end p 99
###begin p 100
###xml 190 195 190 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 240 245 240 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 432 439 432 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 624 625 622 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 745 750 743 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
(B) The constructs were cloned into the pTarget expression vector and transiently transfected in COS7 cells. RT-PCR of the region exon 6 to exon 7 revealed the predominant expression of the LHCGR mRNA lacking exon 6A (wt) for the wild-type LHCGR, while the A557C mutation led to predominant inclusion of exon 6A short and long (A557C). Signal transduction studies were performed as follows: Transfection efficiency was monitored by Renilla luciferase activity. Cells were stimulated by hCG for 3 h and extracellular cAMP was measured by RIA. Results of three independent experiments (mean +/- SEM) are shown. A significant (p = 0.02, Kruskall-Wallis test) dose-dependent increase of cAMP production was observed in the presence of the wild-type LHCGR minigene, whereas the response was abolished in the presence of the A557C mutation in exon 6A (C).
###end p 100
###begin title 101
Discussion
###end title 101
###begin p 102
###xml 62 67 62 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 229 231 229 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050088-b011">11</xref>
###xml 446 448 446 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050088-b012">12</xref>
###xml 575 589 575 589 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Macaca mulatta</named-content>
###xml 677 682 677 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 994 999 994 999 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 1191 1196 1191 1196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 1203 1212 1203 1212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0050088-sg002">Figure S2</xref>
###xml 1215 1217 1215 1217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050088-b013">13</xref>
###xml 1294 1299 1294 1299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 1462 1463 1462 1463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050088-b009">9</xref>
###xml 1464 1466 1464 1466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050088-b010">10</xref>
###xml 97 102 <span type="species:ncbi:9606">human</span>
###xml 285 290 <span type="species:ncbi:9606">human</span>
###xml 429 433 <span type="species:ncbi:4456">apes</span>
###xml 438 444 <span type="species:ncbi:9606">humans</span>
###xml 575 589 <span type="species:ncbi:9544">Macaca mulatta</span>
###xml 795 798 <span type="species:ncbi:10116">rat</span>
###xml 800 805 <span type="species:ncbi:10090">mouse</span>
###xml 807 810 <span type="species:ncbi:9615">dog</span>
We detected a previously unrecognized, functional exon in the LHCGR gene that is present only in human and other primates. The appearance of novel exons in the primate lineage has been described for other receptor genes as well [11]. For example, a novel 5' exon was identified in the human tumor necrosis factor receptor gene type 2, which evolved during evolution from an ALU element to a fully functional exon present only in apes and humans [12]. Exon 6A was detected in all primate species analyzed, and we identified an IMAGE consortium clone from the Old World monkey Macaca mulatta testis in the EST-NCBI database that, despite its poor sequence quality, resembles the LHCGR exon 6A terminal variant. On the other hand, exon 6A-like sequences are not found in nonprimate species such as rat, mouse, dog, and fish. Therefore, this novel exon is confined to primates, where it is highly conserved, indicating strong functional constraints. We suggest that the genomic organization of the LHCGR gene in the primates be revised to include exon 6A, and hypothesize that the mRNA transcript without exon 6A encoding for the known LHCGR protein represents a splicing variant of the revised LHCGR gene (Figure S2) [13]. It is tempting to speculate that the appearance of exon 6A in the primate LHCGR gene is connected with the evolutionary appearance of CG in primates and its function during sexual differentiation and in pregnancy recognition and maintenance [9,10].
###end p 102
###begin p 103
###xml 68 76 68 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050088-g005">Figure 5</xref>
###xml 215 220 215 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 303 311 303 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050088-g004">Figure 4</xref>
###xml 529 534 529 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 324 329 <span type="species:ncbi:302767">comet</span>
Northern blot hybridizations revealed a unique pattern for exon 6A (Figure 5). The strength of the signal obtained with the exon 6A probe, which is at least comparable with the signal intensities of the full-length LHCGR mRNA, corroborates the finding obtained from the relative quantification studies (Figure 4), while the comet-like signal indicates a spectrum of transcripts of various lengths. If, as postulated, exon 6A-containg transcripts undergo NMD this pattern could derive from partially degraded transcripts from the LHCGR exon 6A internal variants and from the terminal exon 6 variant (calculated size approximately 650 bp). A comparison with transcript patterns from other genes/exons undergoing NMD is not possible, since to our knowledge no other data on Northern blot hybridization of such transcripts have yet been performed.
###end p 103
###begin p 104
###xml 282 284 282 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050088-b014">14</xref>
###xml 412 417 412 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 1225 1234 1225 1234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0050088-sg004">Figure S4</xref>
###xml 1237 1239 1237 1239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050088-b015">15</xref>
###xml 1240 1242 1240 1242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050088-b016">16</xref>
###xml 111 116 <span type="species:ncbi:9606">human</span>
###xml 988 995 <span type="species:ncbi:9606">patient</span>
###xml 1075 1083 <span type="species:ncbi:9606">patients</span>
The exact role of exon 6A is not fully understood yet. However, this is the first time to our knowledge that a human disease has been strongly associated with mutations in a cryptic exon that resembles a target for NMD and does not contribute to the final/mature protein structure [14]. We hypothesize that the mutations in exon 6A described in this paper result in modifications of the relative amounts of each LHCGR transcript in the Leydig cells, with highly increased accumulation of variants including exon 6A. This dramatic change overwhelms the NMD machinery and/or alters the pattern of protein translation and transportation, resulting in an insufficient amount of full-length, mature LHCGR protein at the cell surface. This assumption is corroborated by the in vitro functional data demonstrating the incapability of the A557C construct to produce enough functional receptor protein and by the fact that immunohistological staining for the LHCGR in testis sections of the A557C patient was negative, whereas Leydig cells from sections of intact testes and from LCH patients displaying a "classical" inactivating mutation, hindering proper membrane trafficking or signal transduction of the LHCGR, stained positive (Figure S4) [15,16].
###end p 104
###begin p 105
###xml 248 253 248 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 318 326 318 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050088-g008">Figure 8</xref>
###xml 345 350 345 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 417 422 417 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 490 492 490 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050088-b017">17</xref>
###xml 646 651 646 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 952 957 952 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 1095 1100 1095 1100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 1402 1404 1402 1404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050088-b018">18</xref>
###xml 1546 1551 1546 1551 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 1866 1868 1866 1868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050088-b019">19</xref>
###xml 1869 1871 1869 1871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050088-b020">20</xref>
###xml 2004 2006 2004 2006 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0050088-b021">21</xref>
The phenotype of exon 6A mutations, i.e., LCH and 46,XY DSD, is illuminating and supportive for a strong regulatory function of exon 6A. We propose that a complex network, including the novel transcripts described here and involving NMD, regulates LHCGR expression at both the transcriptional and translational level (Figure 8). The spectrum of LHCGR transcripts includes forms with and without exon 6A, but only the LHCGR mRNA transcript lacking exon 6A will lead to a functional protein [17]. The levels of such a "normal" transcript and its translation probably depend on the correct function of two distinct regulatory avenues processing the LHCGR mRNA including exon 6A. On one side the variant in which exon 6A acts as terminal exon may give rise to a protein potentially capable of hormone binding and/or of interaction with the mature LHCGR protein, thereby acting as modifier of hormone action. On the other side the correct processing of the LHCGR transcripts without exon 6A may depend on the elimination by NMD of the variants including the internal exon 6A. This complex pattern of LHCGR transcripts form a network which, considering the strong physiological constraints of LH/CG action, must be tightly regulated. We postulate that the strict regulation of this network is crucial for establishing the correct ratio between the transcripts, which in turn allows proper LHCGR functioning [18]. This view is supported by the fact that the internal and terminal exon 6A transcripts are physiologically detected along with the "normal" LHCGR mRNA in testes and granulosa cells. Should exon 6A be mutated, the NMD machinery might be unable to process the transcripts efficiently and, if a substantial part of them is translated, the functional LHCGR protein will compete with the truncated LHCGR protein derived from terminal and internal exon 6A variants [19,20]. Via dimerization of the full-length LHCGR with the truncated exon 6A variant, this might result in improper receptor trafficking [21].
###end p 105
###begin title 106
###xml 31 36 31 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
Transcriptional Network of the LHCGR Gene
###end title 106
###begin p 107
###xml 57 62 57 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 193 198 193 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 918 923 918 923 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
Hypothetical model of the transcriptional network of the LHCGR gene including the novel exon 6A in the wild type (hollow arrows) or mutated (filled arrows) forms. The primary transcript of the LHCGR gene includes exon 6A, which can then be skipped in the mature mRNA giving rise to the full-length LHCGR protein, or is spliced into the terminal or internal exon 6A variants. Since exon 6A contains a stop codon (asterisk), the terminal variant may be translated into a truncated LHCGR protein, which remains mainly trapped within the cell and could hypothetically interact with the mature, full-length protein. Conversely, the stop codon in the internal 6A variants is recognized by the NMD pathway, which actively eliminates these transcripts. Under physiological conditions, both the mature transcript without exon 6A and the terminal 6A variant are present in roughly equal amounts in cells normally expressing the LHCGR (hollow arrows of equal width). In mutation(s) of exon 6A, the NMD surveillance mechanism is probably inadequate to eliminate the internal exon 6 variants, which accumulate in the cell and alter the relative abundance of the various transcripts, possibly resulting in an excessive increase of truncated LHCGR protein, incompatible with "normal" receptor function.
###end p 107
###begin p 108
###xml 75 80 75 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 19 27 <span type="species:ncbi:9606">patients</span>
Further studies on patients lacking "classical" genetic alterations in the LHCGR will shed new light on the pathophysiological role of exon 6A in LH/CG function and in clinical conditions of LH resistance.
###end p 108
###begin title 109
Supporting Information
###end title 109
###begin title 110
Exon 6A: Sequence Comparison, Phylogeny, and Genomic Organization
###end title 110
###begin p 111
###xml 87 99 87 99 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Homo sapiens</named-content>
###xml 114 129 114 129 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Pan troglodytes</named-content>
###xml 151 170 151 170 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Macaca fascicularis</named-content>
###xml 183 201 183 201 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Callithrix jacchus</named-content>
###xml 215 232 215 232 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Eulemur coronatus</named-content>
###xml 80 85 <span type="species:ncbi:9606">human</span>
###xml 87 99 <span type="species:ncbi:9606">Homo sapiens</span>
###xml 102 112 <span type="species:ncbi:9598">chimpanzee</span>
###xml 114 129 <span type="species:ncbi:9598">Pan troglodytes</span>
###xml 132 149 <span type="species:ncbi:9541">cynomolgus monkey</span>
###xml 151 170 <span type="species:ncbi:9541">Macaca fascicularis</span>
###xml 183 201 <span type="species:ncbi:9483">Callithrix jacchus</span>
###xml 215 232 <span type="species:ncbi:13514">Eulemur coronatus</span>
(A) Upper part: Genomic and cDNA nucleotide sequence comparison of exon 6A from human (Homo sapiens), chimpanzee (Pan troglodytes), cynomolgus monkey (Macaca fascicularis), marmoset (Callithrix jacchus), and lemur (Eulemur coronatus). Identical nucleotides are indicated by an asterisk. Sequences encompassing internal exon 6A are indicated by the grey line, while terminal exon 6A is indicated by a black line. Typical exon elements are given in bold italics or are boxed (poly[A] signal). Lower part: Comparison of the deduced amino acid sequence of exon 6A.
###end p 111
###begin p 112
(B) Evolutionary pedigree of primate lineage evolution after Singer et al. (2004). The approximate time of DNA insertion is indicated by the arrows. Time scale in million of years (mya).
###end p 112
###begin p 113
###xml 111 116 111 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 75 80 <span type="species:ncbi:9606">human</span>
###xml 82 99 <span type="species:ncbi:9541">cynomolgus monkey</span>
###xml 105 110 <span type="species:ncbi:10090">mouse</span>
(C) Revised organization of the genomic region between exon 6 and 7 of the human, cynomolgus monkey, and mouse LHCGR gene. The exonic size is given above and the intronic size below the genomic elements.
###end p 113
###begin p 114
(4.6 MB PDF)
###end p 114
###begin p 115
Click here for additional data file.
###end p 115
###begin title 116
###xml 51 56 51 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 45 50 <span type="species:ncbi:9606">Human</span>
Revised Complete Genomic Organization of the Human LHCGR Gene Now Consisting of 12 Exons
###end title 116
###begin p 117
Exon sizes are given above the boxes, intron sizes below.
###end p 117
###begin p 118
(9 KB PDF)
###end p 118
###begin p 119
Click here for additional data file.
###end p 119
###begin title 120
Immunofluorescence Localization of HA-Tagged LHCGR Proteins in Transiently Transfected COS7 Cells
###end title 120
###begin p 121
(A) HA-tagged, wild-type terminal exon 6A LHCGR.
###end p 121
###begin p 122
(B) HA-tagged, A557C terminal exon 6A LHCGR.
###end p 122
###begin p 123
(C) Full-length HA-tagged LHCGR protein.
###end p 123
###begin p 124
###xml 302 307 <span type="species:ncbi:10090">mouse</span>
Both truncated LHCGR variants, wild-type and mutated, show a predominantly intracellular localization (A and B), while the full-length receptor is localized intracellularly ([C] left) and membrane bound ([C] right). Immunofluorescence was performed using an HA antibody (1:200, Santa Cruz) and an anti-mouse IgG-FITC-labeled secondary antibody (1:64 dilution) and was visualized using either an inverse epifluorescence microscope (Axioskop II, Zeiss, Germany, [A-C] left column) or a confocal microscope (Leica TCS-SL, Germany [A-C] right column). For the confocal analysis the cells were permeabilized. Bar indicates 50 muM.
###end p 124
###begin p 125
(173 KB PDF)
###end p 125
###begin p 126
Click here for additional data file.
###end p 126
###begin title 127
###xml 49 54 <span type="species:ncbi:9606">Human</span>
Immunohistochemical Localization of the LHCGR in Human Testes
###end title 127
###begin p 128
###xml 150 155 150 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 229 234 229 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 89 96 <span type="species:ncbi:9606">patient</span>
###xml 291 298 <span type="species:ncbi:9606">patient</span>
###xml 381 388 <span type="species:ncbi:9606">patient</span>
Leydig cells are positive for LHCGR in normal spermatogenesis (A) and in the testes of a patient with LCH caused by an F194A inactivating mutation in LHCGR (see Gromoll J, et al. [2002] Eur J Endocrinol 147: 597] (B), whereas no LHCGR expression can be detected in Leydig cells of the A557C patient (C). alpha-smooth muscle actin staining was used as positive control for the same patient (D). Bar indicates 100 muM.
###end p 128
###begin p 129
(357 KB PDF)
###end p 129
###begin p 130
Click here for additional data file.
###end p 130
###begin title 131
Functional Characterization of the T461I and the G558C Mutations
###end title 131
###begin p 132
###xml 296 303 296 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
(A) Signal transduction hCG-dependent cAMP-responsive luciferase activity measured in wild-type LHR (filled circle), LHR-T461I mutant receptor (square), and empty expression plasmid pSG5 (triangles) expressing HEK293 cells. The hCG response of the mutant LH receptor is almost completely absent. Renilla, control of transfection efficiency; RLU, relative luciferase units. Construction of the expression plasmid pSG5-LHRWT and pSG5-LHR-T461I, culture and transfection of HEK293 cells, and the determination of cAMP-dependent luciferase response were performed as described previously (see Richter-Unruh A, et al. [2004] J Clin Endocrinol Metab 89: 5161).
###end p 132
###begin p 133
###xml 52 59 <span type="species:ncbi:9606">patient</span>
(B) Sequencing results of the compound heterozygous patient displaying the exon 6A and exon 11 mutations.
###end p 133
###begin p 134
###xml 329 337 329 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050088-g002">Figure 2</xref>
###xml 407 415 407 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0050088-g004">Figure 4</xref>
(C) TaqMan RT-PCR quantification of internal exon 6 A inclusion in exon trap experiments using the wild-type or G558C exon 6A constructs. The expression of internal variants was analyzed after transfection in COS7 cells and RT-PCR of pSPL3 constructs containing the wild type (WT) exon 6A (along with 150 bp 5' and 3' of it: see Figure 2) or exon 6A after introduction of the G558C mutation as described in Figure 4. Densitometric quantification (in arbitrary units (AU) of internal exon 6A variants RT-PCR results (both short and long variant together) of two independent experiments. Results are mean +/- standard error of the mean (SEM).
###end p 134
###begin p 135
(126 KB PDF)
###end p 135
###begin p 136
Click here for additional data file.
###end p 136
###begin title 137
###xml 32 40 <span type="species:ncbi:9606">Patients</span>
Distribution of Exon 6A SNPs in Patients and Controls
###end title 137
###begin p 138
(42 KB DOC)
###end p 138
###begin p 139
Click here for additional data file.
###end p 139
###begin title 140
Accession Numbers
###end title 140
###begin p 141
###xml 70 75 70 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LHCGR</italic>
###xml 158 168 158 168 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. mulatta</named-content>
###xml 64 69 <span type="species:ncbi:9606">human</span>
###xml 158 168 <span type="species:ncbi:9544">M. mulatta</span>
The accession numbers of the items discussed in this paper are: human LHCGR gene (GeneID 3973; ); Leydig cell hypoplasia (MIM 152790); and exon 6A clone from M. mulatta testis (EST database CD766751; ).
###end p 141
###begin p 142
###xml 341 348 <span type="species:ncbi:9606">patient</span>
###xml 402 407 <span type="species:ncbi:9606">human</span>
This paper is dedicated to Prof. Dr. E. Nieschlag and to S. Nieschlag, MA, for their tireless efforts on behalf of reproductive endocrinology and for supporting our work over the years. We thank E. Lahrmann, N. Terwort, and R. Sandhowe for invaluable technical assistance. We are grateful to Prof. Dr. N. Albers for providing the DNA of one patient, to Dr. V. Nordhoff and Dr. S. Kliesch for providing human granulosa cells and testis tissue and to Dr. C. M. Luetjens for histological analysis of testicular samples, immunohistochemistry of LHCGR exon 6A protein expression, and help in preparing the illustrations. The LHCGR antibody was kindly provided Dr. F. Malavasi, University of Turin, Italy.
###end p 142
###begin title 143
Abbreviations
###end title 143
###begin p 144
chorionic gonadotropin
###end p 144
###begin p 145
disorder(s) of sex development
###end p 145
###begin p 146
exon splicing enhancer
###end p 146
###begin p 147
Leydig cell hypoplasia
###end p 147
###begin p 148
luteinizing hormone
###end p 148
###begin p 149
luteinizing hormone chorionic gonadotropin receptor
###end p 149
###begin p 150
nonsense-mediated mRNA decay
###end p 150
###begin p 151
reverse transcription PCR
###end p 151
###begin p 152
standard error of the mean
###end p 152
###begin title 153
References
###end title 153
###begin article-title 154
The lutropin/choriogonadotropin receptor, a 2002 perspective
###end article-title 154
###begin article-title 155
Mutations of gonadotropins and gonadotropin receptors: Elucidating the physiology and pathophysiology of pituitary-gonadal function
###end article-title 155
###begin article-title 156
Evidence for genetic heterogeneity in male pseudohermaphroditism due to Leydig cell hypoplasia. J Clin
###end article-title 156
###begin article-title 157
Leydig cell hypoplasia: cases with new mutations, new polymorphisms and cases without mutations in the luteinizing hormone receptor gene
###end article-title 157
###begin article-title 158
###xml 96 101 <span type="species:ncbi:9606">human</span>
The old world monkey DAZ gene yields insights into the evolution of the DAZ gene cluster on the human Y chromosome
###end article-title 158
###begin article-title 159
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T) method)
###end article-title 159
###begin article-title 160
Point mutations in AAUAAA and the poly (A) addition site: effects on the accuracy and efficiency of cleavage and polyadenylation in vitro
###end article-title 160
###begin article-title 161
A new subclass of the luteinizing hormone/chorionic gonadotropin receptor lacking exon 10 messenger RNA in the New World monkey (Platyrrhini) lineage
###end article-title 161
###begin article-title 162
Chorionic gonadotropin has a recent origin within primates and an evolutionary history of selection
###end article-title 162
###begin article-title 163
###xml 97 103 <span type="species:ncbi:9606">humans</span>
Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans
###end article-title 163
###begin article-title 164
###xml 28 33 <span type="species:ncbi:9606">human</span>
###xml 35 40 <span type="species:ncbi:10090">mouse</span>
###xml 45 48 <span type="species:ncbi:10116">rat</span>
Alternative splicing in the human, mouse and rat genomes is associated with an increased frequency of exon creation and/or loss
###end article-title 164
###begin article-title 165
From "junk" to gene: curriculum vitae of a primate receptor isoform gene
###end article-title 165
###begin article-title 166
Alternative ribonucleic acid processing in endocrine systems
###end article-title 166
###begin article-title 167
Glycoprotein hormone receptors: determinants in leucine-rich repeats responsible for ligand specificity
###end article-title 167
###begin article-title 168
Homozygous mutation within the conserved Ala-Phe-Asn-Glu-Thr motif of exon 7 of the LH receptor causes male pseudohermaphroditism
###end article-title 168
###begin article-title 169
Comparison of immunocytochemical and molecular features with the phenotype in a case of incomplete male pseudohermaphroditism associated with a mutation of the luteinizing hormone receptor
###end article-title 169
###begin article-title 170
###xml 40 45 <span type="species:ncbi:9606">human</span>
###xml 86 91 <span type="species:ncbi:9606">human</span>
Alternately spliced luteinizing hormone/human chorionic gonadotropin receptor mRNA in human breast epithelial cells
###end article-title 170
###begin article-title 171
Functions of alternative splicing
###end article-title 171
###begin article-title 172
###xml 24 29 <span type="species:ncbi:9606">human</span>
###xml 80 85 <span type="species:ncbi:9606">human</span>
A splice variant of the human LH receptor modulates the expression of wild type human LH receptor
###end article-title 172
###begin article-title 173
Requirement of cysteine residues in exons 1-6 of the extracellular domain of the luteinizing hormone receptor for gonadotropin binding
###end article-title 173
###begin article-title 174
Diversifying the repertoire of G protein-coupled receptors through oligomerization
###end article-title 174
###begin p 175
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Author contributions.</bold>
###xml 154 162 <span type="species:ncbi:9606">patients</span>
Author contributions. NK performed the experiments and wrote parts of the manuscript, MS designed experiments and wrote the manuscript, AR-U enrolled the patients, APNT performed the functional experiments on the T461I mutation, and JG designed the study and wrote the manuscript.
###end p 175
###begin p 176
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding:</bold>
Funding: Parts of this study were supported by the German Research Foundation (DFG GR 1547/6-1), by the fund "Innovative Medical Research" of the University of Munster Medical School (SI 110517), and by a US National Institutes of Health grant DK069711. The funding agencies did not have any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 176
###begin p 177
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests:</bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 177

